Sickle Cell Disease news and research updates
Research readouts, treatment and access decisions, and community updates for people living with sickle cell disease and the people who care for them — each one dated, with a link to the original source where there is one.
436 articlesFree, no login required
Looking for earlier coverage? Browse the news archive.
NMAC-HID Allo-HSCT May Be More Cost Effective for SCD
For adults with sickle cell disease (SCD), a cost-effectiveness analysis suggests that treatment with nonmyeloablative haploidentical (NMAC-HID) allogeneic stem cell…
Sickle cell epidemic
June 19 is the annual date the world marks ‘International Sickle Cell Day’. The theme for this year’s own is, “Closing the Survival Gap: Equity in Sickle Cell Care”. Sickle Cell…
CS-206 Seems Safe and Effective in SCD, Patient Data Suggests
The first patient with sickle cell disease (SCD) treated with the base-editing therapy CS-206 in China remained free of vaso-occlusive crises for over 15 months, according to a…
23 year old becomes first person in Louisiana to be functionally cured of sickle cell disease
Daniel Cressy became the first person in the Gulf South to be functionally cured of sickle cell disease through gene editing. Calling it his "second birthday," he said the…
Transplant outperforms standard care for children with sickle cell
Children with sickle cell anemia, the most common and severe form of sickle cell disease (SCD), who undergo stem cell transplant experience better long-term cognitive function…
2026 Warren Alpert Foundation Prize Awarded for Gene-Editing Therapies
The 2026 Warren Alpert Foundation Prize has been awarded to five scientists for their work leading to curative genetic therapies for two major blood disorders: sickle cell disease…
Exercise in Sickle Cell Disease: The Impact on Pathophysiology and Clinical Symptoms
Abstract Sickle cell disease (SCD) is one of the most common inherited blood disorders worldwide. Clinical manifestations are variable, but include hyposplenism, renal impairment…
Vascarta Announces Phase I Results of VAS-101 Administered Sublingually in Sickle Cell Disease Patients
SUMMIT, N.J. , June 24, 2026 /PRNewswire/ -- Vascarta Inc., a clinical-stage biopharmaceutical company advancing innovative treatments for pain and inflammation, announced today…
Windsor doctor recognized for work with sickle cell disease patients
Windsor Regional Hospital's Dr. Andrea Cervi receives the Medical Award of Excellence from the Sickle Cell Awareness Group of Ontario, presented by Dr. Isaac Odame, haematology…
Safety First: Data Gathering Proceeds for Crovalimab SCD Vaso-Occlusive Episode Control
The placebo-controlled phase 1b CROSSWALK-a trial was an evaluation of crovalimab for control of acute vaso-occlusive episodes (VOEs) in sickle cell disease (SCD). Its…
Gene therapy cures metro New Orleans man of sickle cell, clears path for dream of becoming pilot
Daniel Cressy, 23, center, celebrates the end of his Sickle Cell Disease treatment with Lucio Fragoso, CEO of Manning Family Children’s Hospital, left, during a ceremony in…
African health leaders and partners launch new framework to strengthen sickle cell disease care across the continent
NAIROBI, Kenya / KAMPALA, Uganda — African health leaders and partners today launched the Imara Sickle Cell Framework, a new regional initiative designed to help countries…